Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Approach to symptom assessment in palliative care

Victor T Chang, MD
Section Editor
Robert M Arnold, MD
Deputy Editor
Diane MF Savarese, MD


Palliative care is an interdisciplinary medical specialty that focuses on preventing and relieving suffering, and on supporting the best possible quality of life for patients who are facing a serious and/or life-threatening illness and their families [1]. Although some palliative care skills require subspecialty training to learn and apply (eg, negotiating a difficult family meeting, managing refractory symptoms), some core elements of palliative care, such as aligning treatment with a patient’s goals and basic symptom management, should be aspects of the care delivered by all practitioners [2]. Palliative care aims to relieve suffering in all stages of disease and is not limited to end of life care. Within an integrated model of medical care, palliative care is provided at the same time as curative or life-prolonging treatments (algorithm 1). (See "Benefits, services, and models of subspecialty palliative care".)

Patients in the advanced stage of a serious and/or life-threatening illness typically experience multiple symptoms, the most common of which are pain, depression, anxiety, confusion, fatigue, breathlessness, insomnia, nausea, constipation, diarrhea, and anorexia (table 1) [3-6]. Patients who have many symptoms are said to have a high symptom burden. These symptoms may result from a number of factors. Among patients with advanced cancer, for example, symptoms may result from the disease (eg, bone pain from metastases, dyspnea from pleural effusions), from treatment (eg, esophagitis with thoracic radiation therapy), or from other concurrent conditions (eg, osteoarthritis).

This topic review provides a suggested approach to assessment for the most common physical and psychological symptoms that arise in patients receiving palliative care for an advanced serious and/or life-threatening illness. The principles underlying the comprehensive palliative care assessment (which include domains other than physical and psychologic symptoms), and an overview of treatment for symptoms commonly encountered in a palliative care population are provided elsewhere. (See "Overview of comprehensive patient assessment in palliative care" and "Overview of managing common non-pain symptoms in palliative care".)


Patient descriptions of physical symptoms and their severity are the primary data for symptom assessment in palliative care. Exploring patients’ reports of symptoms requires thoroughness, persistence, and patience; this is a fundamental aspect of patient-centered care.

It is important to assess mental status and stamina before starting to elicit information as to the nature and severity of symptoms. Seriously fatigued patients may only be able to answer a few questions briefly, and more than one visit may be necessary. Patients who are confused or delirious will not be able to cooperate fully, making symptom identification and assessment difficult; failure to recognize delirium may lead to inaccurate assessments and inappropriate therapies [7]. (See "Diagnosis of delirium and confusional states".)

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Oct 12, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Sepúlveda C, Marlin A, Yoshida T, Ullrich A. Palliative Care: the World Health Organization's global perspective. J Pain Symptom Manage 2002; 24:91.
  2. Quill TE, Abernethy AP. Generalist plus specialist palliative care--creating a more sustainable model. N Engl J Med 2013; 368:1173.
  3. Reuben DB, Mor V, Hiris J. Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med 1988; 148:1586.
  4. Walsh D, Donnelly S, Rybicki L. The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 2000; 8:175.
  5. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 2006; 31:58.
  6. Moens K, Higginson IJ, Harding R, EURO IMPACT. Are there differences in the prevalence of palliative care-related problems in people living with advanced cancer and eight non-cancer conditions? A systematic review. J Pain Symptom Manage 2014; 48:660.
  7. Coyle N, Breitbart W, Weaver S, Portenoy R. Delirium as a contributing factor to "crescendo" pain: three case reports. J Pain Symptom Manage 1994; 9:44.
  8. Homsi J, Walsh D, Rivera N, et al. Symptom evaluation in palliative medicine: patient report vs systematic assessment. Support Care Cancer 2006; 14:444.
  9. Laugsand EA, Sprangers MA, Bjordal K, et al. Health care providers underestimate symptom intensities of cancer patients: a multicenter European study. Health Qual Life Outcomes 2010; 8:104.
  10. Xiao C, Polomano R, Bruner DW. Comparison between patient-reported and clinician-observed symptoms in oncology. Cancer Nurs 2013; 36:E1.
  11. Yennurajalingam S, Urbauer DL, Casper KL, et al. Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic. J Pain Symptom Manage 2011; 41:49.
  12. Williams PD, Graham KM, Storlie DL, et al. Therapy-related symptom checklist use during treatments at a cancer center. Cancer Nurs 2013; 36:245.
  13. Hoekstra J, Vernooij-Dassen MJ, de Vos R, Bindels PJ. The added value of assessing the 'most troublesome' symptom among patients with cancer in the palliative phase. Patient Educ Couns 2007; 65:223.
  14. Mehta A, Ezer H. My love is hurting: the meaning spouses attribute to their loved ones' pain during palliative care. J Palliat Care 2003; 19:87.
  15. Dudel, J. General sensory physiology, psychophysics. In: Fundamentals of sensory physiology, General sensory physiology, psychophysics (Eds), Springer Verlag, New York 1977. p.1.
  16. Oldenmenger WH, de Raaf PJ, de Klerk C, van der Rijt CC. Cut points on 0-10 numeric rating scales for symptoms included in the Edmonton Symptom Assessment Scale in cancer patients: a systematic review. J Pain Symptom Manage 2013; 45:1083.
  17. Sze FK, Chung TK, Wong E, et al. Pain in Chinese cancer patients under palliative care. Palliat Med 1998; 12:271.
  18. Farrar JT, Young JP Jr, LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001; 94:149.
  19. Cella D, Zagari MJ, Vandoros C, et al. Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population. J Clin Oncol 2003; 21:366.
  20. Schwartz AL, Meek PM, Nail LM, et al. Measurement of fatigue. determining minimally important clinical differences. J Clin Epidemiol 2002; 55:239.
  21. de Torres JP, Pinto-Plata V, Ingenito E, et al. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest 2002; 121:1092.
  22. Witek TJ Jr, Mahler DA. Meaningful effect size and patterns of response of the transition dyspnea index. J Clin Epidemiol 2003; 56:248.
  23. Grossman SA, Sheidler VR, Swedeen K, et al. Correlation of patient and caregiver ratings of cancer pain. J Pain Symptom Manage 1991; 6:53.
  24. Passik SD, Dugan W, McDonald MV, et al. Oncologists' recognition of depression in their patients with cancer. J Clin Oncol 1998; 16:1594.
  25. Marquié L, Raufaste E, Lauque D, et al. Pain rating by patients and physicians: evidence of systematic pain miscalibration. Pain 2003; 102:289.
  26. Sutherland JE, Wesley RM, Cole PM, et al. Differences and similarities between patient and physician perceptions of patient pain. Fam Med 1988; 20:343.
  27. Lesho E, Foster L, Wang Z, et al. The accuracy of physicians' perceptions of patients' suffering: findings from two teaching hospitals. Acad Med 2009; 84:636.
  28. Kurtz ME, Kurtz JC, Given CC, Given B. Concordance of cancer patient and caregiver symptom reports. Cancer Pract 1996; 4:185.
  29. Silveira MJ, Given CW, Given B, et al. Patient-caregiver concordance in symptom assessment and improvement in outcomes for patients undergoing cancer chemotherapy. Chronic Illn 2010; 6:46.
  30. McMillan SC, Moody LE. Hospice patient and caregiver congruence in reporting patients' symptom intensity. Cancer Nurs 2003; 26:113.
  31. Koffman J, Morgan M, Edmonds P, et al. Cultural meanings of pain: a qualitative study of Black Caribbean and White British patients with advanced cancer. Palliat Med 2008; 22:350.
  32. Wang XS, Cleeland CS, Mendoza TR, et al. Impact of cultural and linguistic factors on symptom reporting by patients with cancer. J Natl Cancer Inst 2010; 102:732.
  33. Radbruch L, Strasser F, Elsner F, et al. Fatigue in palliative care patients -- an EAPC approach. Palliat Med 2008; 22:13.
  34. Campbell ML, Templin T, Walch J. A Respiratory Distress Observation Scale for patients unable to self-report dyspnea. J Palliat Med 2010; 13:285.
  35. Campbell ML, Kero KK, Templin TN. Mild, moderate, and severe intensity cut-points for the Respiratory Distress Observation Scale. Heart Lung 2017; 46:14.
  36. Nekolaichuk CL, Maguire TO, Suarez-Almazor M, et al. Assessing the reliability of patient, nurse, and family caregiver symptom ratings in hospitalized advanced cancer patients. J Clin Oncol 1999; 17:3621.
  37. Redinbaugh EM, Baum A, DeMoss C, et al. Factors associated with the accuracy of family caregiver estimates of patient pain. J Pain Symptom Manage 2002; 23:31.
  38. Saleem TZ, Higginson IJ, Chaudhuri KR, et al. Symptom prevalence, severity and palliative care needs assessment using the Palliative Outcome Scale: a cross-sectional study of patients with Parkinson's disease and related neurological conditions. Palliat Med 2013; 27:722.
  39. Harding R, Selman L, Agupio G, et al. Prevalence, burden, and correlates of physical and psychological symptoms among HIV palliative care patients in sub-Saharan Africa: an international multicenter study. J Pain Symptom Manage 2012; 44:1.
  40. Lokker ME, Offerman MP, van der Velden LA, et al. Symptoms of patients with incurable head and neck cancer: prevalence and impact on daily functioning. Head Neck 2013; 35:868.
  41. Watanabe SM, Nekolaichuk C, Beaumont C, et al. A multicenter study comparing two numerical versions of the Edmonton Symptom Assessment System in palliative care patients. J Pain Symptom Manage 2011; 41:456.
  42. Hahn EA, Cella D, Chassany O, et al. Precision of health-related quality-of-life data compared with other clinical measures. Mayo Clin Proc 2007; 82:1244.
  43. Jacox, A, Carr, et al. Management of cancer pain. Clinical practice guideline, #9, Agency for Health Care Policy and Research, Rockville, MD 1994.
  44. Serlin RC, Mendoza TR, Nakamura Y, et al. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 1995; 61:277.
  45. Jeon S, Given CW, Sikorskii A, Given B. Do interference-based cut-points differentiate mild, moderate, and severe levels of 16 cancer-related symptoms over time? J Pain Symptom Manage 2009; 37:220.
  46. Chang VT, Hwang SS, Feuerman M, et al. The memorial symptom assessment scale short form (MSAS-SF). Cancer 2000; 89:1162.
  47. Chang VT, Hwang SS, Kasimis B, Thaler HT. Shorter symptom assessment instruments: the Condensed Memorial Symptom Assessment Scale (CMSAS). Cancer Invest 2004; 22:526.
  48. Tranmer JE, Heyland D, Dudgeon D, et al. Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale. J Pain Symptom Manage 2003; 25:420.
  49. Cleeland CS, Mendoza TR, Wang XS, et al. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer 2000; 89:1634.
  50. M D Anderson Sysmptom Assessment Scale www.mdanderson.org/departments/prg/display.cfm?id=0EE78C60-6646-11D5-812400508B603A14&pn=0EE78204-6646-11D5-812400508B603A14&method=displayfull (Accessed on February 01, 2011).
  51. de Haes JC, van Knippenberg FC, Neijt JP. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 1990; 62:1034.
  52. McCorkle R. The measurement of symptom distress. Semin Oncol Nurs 1987; 3:248.
  53. Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983; 17:197.
  54. A sample version of the Brief Pain Inventory http://www.painknowledge.org/physiciantools/opioid_toolkit/components/BPI.pdf (Accessed on February 01, 2011).
  55. Lunney JR, Lynn J, Foley DJ, et al. Patterns of functional decline at the end of life. JAMA 2003; 289:2387.
  56. Ho F, Lau F, Downing MG, Lesperance M. A reliability and validity study of the Palliative Performance Scale. BMC Palliat Care 2008; 7:10.
  57. Anderson F, Downing GM, Hill J, et al. Palliative performance scale (PPS): a new tool. J Palliat Care 1996; 12:5.
  58. Components of the palliative performance scale (PPS) available online at http://pallipedia.org/term.php?id=504 (Accessed on March 14, 2011).
  59. Ma C, Bandukwala S, Burman D, et al. Interconversion of three measures of performance status: an empirical analysis. Eur J Cancer 2010; 46:3175.
  60. Chang VT, Hwang SS, Feuerman M, Kasimis BS. Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: a role for symptom assessment. Cancer 2000; 88:1175.
  61. Seow H, Barbera L, Sutradhar R, et al. Trajectory of performance status and symptom scores for patients with cancer during the last six months of life. J Clin Oncol 2011; 29:1151.
  62. Viganò A, Dorgan M, Buckingham J, et al. Survival prediction in terminal cancer patients: a systematic review of the medical literature. Palliat Med 2000; 14:363.
  63. Bruera E, Kuehn N, Miller MJ, et al. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 1991; 7:6.
  64. Maltoni M, Pirovano M, Scarpi E, et al. Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric study. Cancer 1995; 75:2613.
  65. Escalante CP, Martin CG, Elting LS, et al. Identifying risk factors for imminent death in cancer patients with acute dyspnea. J Pain Symptom Manage 2000; 20:318.
  66. Kåss RM, Ellershaw J. Respiratory tract secretions in the dying patient: a retrospective study. J Pain Symptom Manage 2003; 26:897.
  67. Blinderman CD, Homel P, Billings JA, et al. Symptom distress and quality of life in patients with advanced congestive heart failure. J Pain Symptom Manage 2008; 35:594.
  68. Rustøen T, Stubhaug A, Eidsmo I, et al. Pain and quality of life in hospitalized patients with heart failure. J Pain Symptom Manage 2008; 36:497.
  69. Lynn J, Ely EW, Zhong Z, et al. Living and dying with chronic obstructive pulmonary disease. J Am Geriatr Soc 2000; 48:S91.
  70. Roth K, Lynn J, Zhong Z, et al. Dying with end stage liver disease with cirrhosis: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. J Am Geriatr Soc 2000; 48:S122.
  71. Smith AK, Cenzer IS, Knight SJ, et al. The epidemiology of pain during the last 2 years of life. Ann Intern Med 2010; 153:563.
  72. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975; 1:277.
  73. Melzack R. The short-form McGill Pain Questionnaire. Pain 1987; 30:191.
  74. Gauthier LR, Young A, Dworkin RH, et al. Validation of the short-form McGill pain questionnaire-2 in younger and older people with cancer pain. J Pain 2014; 15:756.
  75. Fishman B, Pasternak S, Wallenstein SL, et al. The Memorial Pain Assessment Card. A valid instrument for the evaluation of cancer pain. Cancer 1987; 60:1151.
  76. Rhudy JL, Meagher MW. Fear and anxiety: divergent effects on human pain thresholds. Pain 2000; 84:65.
  77. Puntillo KA, White C, Morris AB, et al. Patients' perceptions and responses to procedural pain: results from Thunder Project II. Am J Crit Care 2001; 10:238.
  78. Whitcomb LA, Kirsh KL, Passik SD. Substance abuse issues in cancer pain. Curr Pain Headache Rep 2002; 6:183.
  79. Dunbar SA, Katz NP. Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: report of 20 cases. J Pain Symptom Manage 1996; 11:163.
  80. Herr K, Coyne PJ, McCaffery M, et al. Pain assessment in the patient unable to self-report: position statement with clinical practice recommendations. Pain Manag Nurs 2011; 12:230.
  81. Warden V, Hurley AC, Volicer L. Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale. J Am Med Dir Assoc 2003; 4:9.
  82. Kovach CR, Noonan PE, Griffie J, et al. The assessment of discomfort in dementia protocol. Pain Manag Nurs 2002; 3:16.
  83. http://prc.coh.org/PAIN-NOA.htm (Accessed on May 18, 2010).
  84. Herr K, Bursch H, Ersek M, et al. Use of pain-behavioral assessment tools in the nursing home: expert consensus recommendations for practice. J Gerontol Nurs 2010; 36:18.
  85. http://prc.coh.org/PAIN-NOA.htm (Accessed on February 25, 2013).
  86. Thomas JR, von Gunten CF. Management of dyspnea. J Support Oncol 2003; 1:23.
  87. Reuben DB, Mor V. Dyspnea in terminally ill cancer patients. Chest 1986; 89:234.
  88. Dudgeon DJ, Lertzman M, Askew GR. Physiological changes and clinical correlations of dyspnea in cancer outpatients. J Pain Symptom Manage 2001; 21:373.
  89. Bruera E, Schmitz B, Pither J, et al. The frequency and correlates of dyspnea in patients with advanced cancer. J Pain Symptom Manage 2000; 19:357.
  90. McGavin CR, Artvinli M, Naoe H, McHardy GJ. Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease. Br Med J 1978; 2:241.
  91. Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med 1970; 2:92.
  92. Williams JE, Singh SJ, Sewell L, et al. Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR). Thorax 2001; 56:954.
  93. Uronis HE, Shelby RA, Currow DC, et al. Assessment of the psychometric properties of an English version of the cancer dyspnea scale in people with advanced lung cancer. J Pain Symptom Manage 2012; 44:741.
  94. Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 1999; 85:1186.
  95. Kinsman RA, Yaroush RA, Fernandez E, et al. Symptoms and experiences in chronic bronchitis and emphysema. Chest 1983; 83:755.
  96. Feinstein AR, Fisher MB, Pigeon JG. Changes in dyspnea-fatigue ratings as indicators of quality of life in the treatment of congestive heart failure. Am J Cardiol 1989; 64:50.
  97. Hwang SS, Chang VT, Kasimis BS. A comparison of three fatigue measures in veterans with cancer. Cancer Invest 2003; 21:363.
  98. Davies AN, Broadley K, Beighton D. Xerostomia in patients with advanced cancer. J Pain Symptom Manage 2001; 22:820.
  99. Sweeney MP, Bagg J. The mouth and palliative care. Am J Hosp Palliat Care 2000; 17:118.
  100. Ribaudo JM, Cella D, Hahn EA, et al. Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire. Qual Life Res 2000; 9:1137.
  101. Thoresen L, Fjeldstad I, Krogstad K, et al. Nutritional status of patients with advanced cancer: the value of using the subjective global assessment of nutritional status as a screening tool. Palliat Med 2002; 16:33.
  102. Corli O, Cozzolino A, Battaiotto L, et al. A new method of food intake quantification: application to the care of cancer patients. J Pain Symptom Manage 1992; 7:12.
  103. Sarkisian CA, Lachs MS. "Failure to thrive" in older adults. Ann Intern Med 1996; 124:1072.
  104. Hamerman D. Toward an understanding of frailty. Ann Intern Med 1999; 130:945.
  105. Wood GJ, Shega JW, Lynch B, Von Roenn JH. Management of intractable nausea and vomiting in patients at the end of life: "I was feeling nauseous all of the time . . . nothing was working". JAMA 2007; 298:1196.
  106. Erichsén E, Milberg A, Jaarsma T, Friedrichsen M. Constipation in specialized palliative care: factors related to constipation when applying different definitions. Support Care Cancer 2016; 24:691.
  107. Clark K, Currow DC. Constipation in palliative care: what do we use as definitions and outcome measures? J Pain Symptom Manage 2013; 45:753.
  108. Mearin F, Lacy BE, Chang L, et al. Bowel Disorders. Gastroenterology 2016.
  109. Rentz AM, Yu R, Müller-Lissner S, Leyendecker P. Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation. J Med Econ 2009; 12:371.
  110. Ueberall MA, Müller-Lissner S, Buschmann-Kramm C, Bosse B. The Bowel Function Index for evaluating constipation in pain patients: definition of a reference range for a non-constipated population of pain patients. J Int Med Res 2011; 39:41.
  111. Abramowitz L, Béziaud N, Caussé C, et al. Further validation of the psychometric properties of the Bowel Function Index for evaluating opioid-induced constipation (OIC). J Med Econ 2013; 16:1434.
  112. Argoff CE, Brennan MJ, Camilleri M, et al. Consensus Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation. Pain Med 2015; 16:2324.
  113. McMillan SC. Presence and severity of constipation in hospice patients with advanced cancer. Am J Hosp Palliat Care 2002; 19:426.
  114. McMillan SC, Williams FA. Validity and reliability of the Constipation Assessment Scale. Cancer Nurs 1989; 12:183.
  115. Librach SL, Bouvette M, De Angelis C, et al. Consensus recommendations for the management of constipation in patients with advanced, progressive illness. J Pain Symptom Manage 2010; 40:761.
  116. Clemens KE, Klaschik E. Management of constipation in palliative care patients. Curr Opin Support Palliat Care 2008; 2:22.
  117. Rao SS, Ozturk R, Laine L. Clinical utility of diagnostic tests for constipation in adults: a systematic review. Am J Gastroenterol 2005; 100:1605.
  118. Rao SS, Meduri K. What is necessary to diagnose constipation? Best Pract Res Clin Gastroenterol 2011; 25:127.
  119. Bruera E, Suarez-Almazor M, Velasco A, et al. The assessment of constipation in terminal cancer patients admitted to a palliative care unit: a retrospective review. J Pain Symptom Manage 1994; 9:515.
  120. Starreveld JS, Pols MA, Van Wijk HJ, et al. The plain abdominal radiograph in the assessment of constipation. Z Gastroenterol 1990; 28:335.
  121. Clark K, Lam LT, Talley NJ, et al. Assessing the Presence and Severity of Constipation with Plain Radiographs in Constipated Palliative Care Patients. J Palliat Med 2016; 19:617.
  122. Cowlam S, Vinayagam R, Khan U, et al. Blinded comparison of faecal loading on plain radiography versus radio-opaque marker transit studies in the assessment of constipation. Clin Radiol 2008; 63:1326.
  123. Nagaviroj K, Yong WC, Fassbender K, et al. Comparison of the Constipation Assessment Scale and plain abdominal radiography in the assessment of constipation in advanced cancer patients. J Pain Symptom Manage 2011; 42:222.
  124. Brandt LJ, Prather CM, Quigley EM, et al. Systematic review on the management of chronic constipation in North America. Am J Gastroenterol 2005; 100 Suppl 1:S5.
  125. Ternent CA, Bastawrous AL, Morin NA, et al. Practice parameters for the evaluation and management of constipation. Dis Colon Rectum 2007; 50:2013.
  126. Bruera E. Patient assessment in palliative cancer care. Cancer Treat Rev 1996; 22 Suppl A:3.
  127. Pyszel A, Malyszczak K, Pyszel K, et al. Disability, psychological distress and quality of life in breast cancer survivors with arm lymphedema. Lymphology 2006; 39:185.
  128. Todd M. Understanding lymphoedema in advanced disease in a palliative care setting. Int J Palliat Nurs 2009; 15:474, 476.
  129. Frid M, Strang P, Friedrichsen MJ, Johansson K. Lower limb lymphedema: experiences and perceptions of cancer patients in the late palliative stage. J Palliat Care 2006; 22:5.
  130. International classification of sleep disorders, 3rd ed., American Academy of Sleep Medicine, Darien, IL 2014.
  131. Kvale EA, Shuster JL. Sleep disturbance in supportive care of cancer: a review. J Palliat Med 2006; 9:437.
  132. Hugel H, Ellershaw JE, Cook L, et al. The prevalence, key causes and management of insomnia in palliative care patients. J Pain Symptom Manage 2004; 27:316.
  133. Mercadante S, Aielli F, Adile C, et al. Sleep Disturbances in Patients With Advanced Cancer in Different Palliative Care Settings. J Pain Symptom Manage 2015; 50:786.
  134. Glynn J, Gale S, Tank S. Causes of sleep disturbance in a specialist palliative care unit. BMJ Support Palliat Care 2014; 4 Suppl 1:A56.
  135. Mystakidou K, Tsilika E, Parpa E, et al. Psychological distress of patients with advanced cancer: influence and contribution of pain severity and pain interference. Cancer Nurs 2006; 29:400.
  136. Block SD. Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians - American Society of Internal Medicine. Ann Intern Med 2000; 132:209.
  137. Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011; 12:160.
  138. ZUNG WW. A SELF-RATING DEPRESSION SCALE. Arch Gen Psychiatry 1965; 12:63.
  139. Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer 2009; 115:5349.
  140. Coyle N, Sculco L. Expressed desire for hastened death in seven patients living with advanced cancer: a phenomenologic inquiry. Oncol Nurs Forum 2004; 31:699.
  141. Chochinov HM, Wilson KG, Enns M, Lander S. "Are you depressed?" Screening for depression in the terminally ill. Am J Psychiatry 1997; 154:674.
  142. Mitchell AJ. Are one or two simple questions sufficient to detect depression in cancer and palliative care? A Bayesian meta-analysis. Br J Cancer 2008; 98:1934.
  143. Akizuki N, Yamawaki S, Akechi T, et al. Development of an Impact Thermometer for use in combination with the Distress Thermometer as a brief screening tool for adjustment disorders and/or major depression in cancer patients. J Pain Symptom Manage 2005; 29:91.
  144. Mitchell AJ. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol 2007; 25:4670.
  145. Stark D, Kiely M, Smith A, et al. Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol 2002; 20:3137.
  146. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), American Psychiatric Association, Arlington 2013.
  147. Breitbart W, Alici Y. Evidence-based treatment of delirium in patients with cancer. J Clin Oncol 2012; 30:1206.
  148. Caraceni A, Nanni O, Maltoni M, et al. Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative Care. Cancer 2000; 89:1145.
  149. de la Cruz M, Ransing V, Yennu S, et al. The Frequency, Characteristics, and Outcomes Among Cancer Patients With Delirium Admitted to an Acute Palliative Care Unit. Oncologist 2015; 20:1425.
  150. Wada T, Wada M, Wada M, Onishi H. Characteristics, interventions, and outcomes of misdiagnosed delirium in cancer patients. Palliat Support Care 2010; 8:125.
  151. Massie MJ, Miller K. Oncology. In: The American Psychiatric Publishing Textbook of Psychosomatic Medicine: Psychiatric Care of the Medically Ill, Second Edition, James L. Levenson (Ed), American Psychiatric Publishing, Inc, Washington, DC 2011. p.525.
  152. Lawlor PG, Gagnon B, Mancini IL, et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med 2000; 160:786.
  153. Bruera E, Neumann CM. Management of specific symptom complexes in patients receiving palliative care. CMAJ 1998; 158:1717.
  154. Inouye SK, van Dyck CH, Alessi CA, et al. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med 1990; 113:941.
  155. Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 2001; 286:2703.
  156. Wei LA, Fearing MA, Sternberg EJ, Inouye SK. The Confusion Assessment Method: a systematic review of current usage. J Am Geriatr Soc 2008; 56:823.
  157. Breitbart W, Rosenfeld B, Roth A, et al. The Memorial Delirium Assessment Scale. J Pain Symptom Manage 1997; 13:128.
  158. Lawlor PG, Nekolaichuk C, Gagnon B, et al. Clinical utility, factor analysis, and further validation of the memorial delirium assessment scale in patients with advanced cancer: Assessing delirium in advanced cancer. Cancer 2000; 88:2859.
  159. Sarhill N, Walsh D, Nelson KA, et al. Assessment of delirium in advanced cancer: the use of the bedside confusion scale. Am J Hosp Palliat Care 2001; 18:335.
  160. Wagner LI, Schink J, Bass M, et al. Bringing PROMIS to practice: brief and precise symptom screening in ambulatory cancer care. Cancer 2015; 121:927.
  161. Strasser F, Blum D, von Moos R, et al. The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06). Ann Oncol 2016; 27:324.
  162. Dudgeon D, King S, Howell D, et al. Cancer Care Ontario's experience with implementation of routine physical and psychological symptom distress screening. Psychooncology 2012; 21:357.
  163. Jensen RE, Snyder CF, Abernethy AP, et al. Review of electronic patient-reported outcomes systems used in cancer clinical care. J Oncol Pract 2014; 10:e215.
  164. Basch E, Deal AM, Kris MG, et al. Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial. J Clin Oncol 2016; 34:557.
  165. Evantash E. Vaginal Fetal Fibronectin to Predict Spontaneous Preterm Birth. JAMA 2017; 318:198.
  166. Mooney KH, Beck SL, Friedman RH, et al. Automated monitoring of symptoms during ambulatory chemotherapy and oncology providers' use of the information: a randomized controlled clinical trial. Support Care Cancer 2014; 22:2343.
  167. Kluetz PG, Chingos DT, Basch EM, Mitchell SA. Patient-Reported Outcomes in Cancer Clinical Trials: Measuring Symptomatic Adverse Events With the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Am Soc Clin Oncol Educ Book 2016; 35:67.
  168. Seow H, Sussman J, Martelli-Reid L, et al. Do high symptom scores trigger clinical actions? An audit after implementing electronic symptom screening. J Oncol Pract 2012; 8:e142.
  169. Pereira JL, Chasen MR, Molloy S, et al. Cancer Care Professionals' Attitudes Toward Systematic Standardized Symptom Assessment and the Edmonton Symptom Assessment System After Large-Scale Population-Based Implementation in Ontario, Canada. J Pain Symptom Manage 2016; 51:662.
  170. Abernethy AP, Ahmad A, Zafar SY, et al. Electronic patient-reported data capture as a foundation of rapid learning cancer care. Med Care 2010; 48:S32.
  171. Fortney JC, Unützer J, Wrenn G, et al. A Tipping Point for Measurement-Based Care. Psychiatr Serv 2017; 68:179.
Topic Outline